T2762
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for T2762, covering 2016-04-06 to 2017-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome [NA]